ConductScience.org, home

Paper657182

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

Neugebauer G. Cardiovasc Res, 1978. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog. Papers, record 657182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/657182

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.
PubMed
Journal
Cardiovasc Res
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
7.03
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Neugebauer GG

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular SystemMajor topic
VerapamilMajor topic
Animals
Coronary Circulation
Dogs
Hemodynamics
Myocardial Contraction
Vascular Resistance

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
37983978A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.Clin Pharmacol Ther2024https://conductscience.org/library/papers/37983978PubMed
36763530The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/36763530PubMed
27531061Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.Biochem Pharmacol2016https://conductscience.org/library/papers/27531061PubMed
26823559Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.Biosci Rep2016https://conductscience.org/library/papers/26823559PubMed
24532601Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.J Infect Dis2014https://conductscience.org/library/papers/24532601PubMed
21592185Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.Br J Clin Pharmacol2011https://conductscience.org/library/papers/21592185PubMed
20222974Effect of levosimendan in experimental verapamil-induced myocardial depression.Scand J Trauma Resusc Emerg Med2010https://conductscience.org/library/papers/20222974PubMed
15128524Transformation of verapamil by Cunninghamella blakesleeana.Appl Environ Microbiol2004https://conductscience.org/library/papers/15128524PubMed
9569055Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.Br J Cancer1998https://conductscience.org/library/papers/9569055PubMed
8398588R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8398588PubMed
7710958Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.Br J Cancer1995https://conductscience.org/library/papers/7710958PubMed
7206587Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment.Klin Wochenschr1980https://conductscience.org/library/papers/7206587PubMed
7128672Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7128672PubMed
6934538Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6934538PubMed
6404580Reliability of antiarrhythmic drug plasma concentration monitoring.Clin Pharmacokinet1983https://conductscience.org/library/papers/6404580PubMed
6362951Clinical pharmacokinetics of verapamil.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362951PubMed
6339196Calcium antagonists. Pharmacokinetic properties.Drugs1983https://conductscience.org/library/papers/6339196PubMed
4065190Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4065190PubMed
4029246Pharmacokinetics of verapamil in patients with renal failure.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4029246PubMed
3803414Pharmacokinetics of verapamil in patients with hypertension.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3803414PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/657182

GET https://conductscience.org/api/papers/v1/657182/cited_by?page=2